Provided by Tiger Trade Technology Pte. Ltd.

GT Biopharma Inc.

6.68
+0.720012.08%
Post-market: 6.820.1413+2.12%19:56 EDT
Volume:43.38K
Turnover:268.76K
Market Cap:12.05M
PE:-0.51
High:6.68
Open:5.96
Low:5.83
Close:5.96
52wk High:28.75
52wk Low:4.91
Shares:1.80M
Float Shares:1.74M
Volume Ratio:1.24
T/O Rate:2.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.2195
EPS(LYR):-156.2099
ROE:-113.52%
ROA:-158.16%
PB:3.38
PE(LYR):-0.04

Loading ...

Oct 09, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 26, 2026

Major Issues Report

Form 8-K - Current report
Sep 22, 2026

Major Issues Report

Form 8-K - Current report
Sep 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Sep 15, 2026

Major Issues Report

Form 8-K - Current report
Sep 03, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 12, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2026

Correspondence

Form CORRESP - Correspondence
Apr 30, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 07, 2026

Major Issues Report

Form 8-K - Current report
Mar 06, 2026

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Mar 06, 2026

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Mar 02, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Jan 29, 2026

Correspondence

Form CORRESP - Correspondence
Jan 21, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933